FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

THAM Solution (Tromethamine Injection)
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Hospira, Inc. (Revised 05/24/2016)

Company Contact Information:

Presentation Posting Date Related Information
500 mL Glass Bottle (NDC 0409-1593-04) 05/24/2016 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English